XORTX Therapeutics Statistics
NASDAQ: XRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.839-0.051 (-5.73%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
XORTX Therapeutics by the numbers
XORTX Therapeutics has a market capitalization of $1.9 million based on 2.25M shares outstanding. With trailing EPS of $-2.09, XORTX Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.6% below its 50-day average and 58.0% below its 200-day average.
Average daily trading volume is 776.48K shares, or about $651,468 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XRTX valuation vs. peer median
| Metric | XRTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.88M | $1.92M | -2% |
| Avg. volume | 776.48K | 178.77K | +334% |
Peer median across 8 companies: EOCN, PPCB, PPBT, SBFM, GNPX, DCOY, REVB, ENLV.
Valuation
- Market cap
- $1.88M
- Forward P/E
- 1.05
- EPS (TTM)
- $-2.09
- Shares outstanding
- 2.25M
Price and trading
- Previous close
- 0.89
- Open
- 0.878
- Day range
- 0.8101 – 0.878
- 52-week range
- 0.81 – 3.60
- Beta
- —
- Volume
- 47.88K
- Average volume
- 776.48K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 1.88M
- Forward Pe
- 1.05
- Eps
- -2.09
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.60
- Week52 Low
- 0.81
- Avg Volume
- 776.48K
- Shares Outstanding
- 2.25M
- Ma50
- 1.34
- Ma200
- 2.00
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -76.69%
- Pct From52w Low
- 3.58%